Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma
Tianyi Liu, Linli Zhou, Yao Xiao, et al.
Cancer Research (2022) Vol. 82, Iss. 3, pp. 419-432
Open Access | Times Cited: 25

Showing 25 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models
Jiemiao Hu, Alexander J. Lazar, Davis R. Ingram, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e006991-e006991
Open Access | Times Cited: 17
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 470-470
Open Access | Times Cited: 16
What is new in cancer-associated fibroblast biomarkers?
Zehua Zhao, Tianming Li, Yuan Yuan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Periostin secreted from podoplanin‐positive cancer‐associated fibroblasts promotes metastasis of gastric cancer by regulating cancer stem cells via AKT and YAP signaling pathway
Zhenxiong Zhao, Yanqiu Zhang, Ergang Guo, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 5, pp. 685-699
Closed Access | Times Cited: 20
POSTN Secretion by Extracellular Matrix Cancer-Associated Fibroblasts (eCAFs) Correlates with Poor ICB Response via Macrophage Chemotaxis Activation of Akt Signaling Pathway in Gastric Cancer
Tingting You, Hui Tang, Wenjing Wu, et al.
Aging and Disease (2023) Vol. 14, Iss. 6, pp. 2177-2177
Open Access | Times Cited: 18
Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
Naji Kharouf, Thomas W. Flanagan, Sofie-Yasmin Hassan, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3147-3147
Open Access | Times Cited: 11
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
Yao Xiao, Linli Zhou, Thomas Andl, et al.
Oncogene (2024) Vol. 43, Iss. 12, pp. 884-898
Open Access | Times Cited: 4
The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation–Ubiquitylation Crosstalk of HMGA2
Lingkai Gu, Zhangjin Shen, Shizhen Shen, et al.
Advanced Science (2025)
Open Access
The Dynamic Interplay between Melanoma Cells and CAFs: Implications Drug Resistance and Immune Evasion and Possible Therapeutics
Chou‐Yi Hsu, Raed Obaid Saleh, Mohammed Sani Jaafaru, et al.
Experimental Cell Research (2025), pp. 114581-114581
Closed Access
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
Pradip De, Jennifer C. Aske, Raed Sulaiman, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1519-1519
Open Access | Times Cited: 17
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor
Yuan Yang, Zefei Li, Yidong Wang, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 885-903
Open Access | Times Cited: 3
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
Taku Fujimura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4044-4044
Open Access | Times Cited: 13
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Qiaoqiao Liu, Fei Yao, Liangliang Wu, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2395-2417
Closed Access | Times Cited: 2
Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance
Jeļena Vasiļevska, Phil F. Cheng, Julia Lehmann, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101611-101611
Open Access | Times Cited: 2
Targeting anticancer immunity in melanoma tumor microenvironment: Unleashing the potential of adjuvants, drugs, and phytochemicals
Jingping Wang, Yaping Wang, Xiaofang Jiang
Journal of drug targeting (2024) Vol. 32, Iss. 9, pp. 1052-1072
Closed Access | Times Cited: 2
The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance
Julia Elisabeth Fromme, Paola Zigrino
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects
Junying Gao, Yan Ma, Guiwen Yang, et al.
Journal of Zhejiang University SCIENCE B (2022) Vol. 23, Iss. 8, pp. 642-654
Open Access | Times Cited: 9
CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects
Winston Hibler, Glenn Merlino, Yanlin Yu
Cells (2023) Vol. 12, Iss. 23, pp. 2750-2750
Open Access | Times Cited: 4
The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
Yongmin Li, Fei Liu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategies
Georgia Mitsa, Livia Florianova, J. LaFleur, et al.
Cancer Research Communications (2024)
Open Access
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
Yao Xio, Linli Zhou, Thomas Andl, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
Yuhang Zhang, Yao Xiao, Linli Zhou, et al.
Research Square (Research Square) (2023)
Open Access
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
Yao Xiao, Linli Zhou, Thomas Andl, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top